Literature DB >> 11004701

Expression of angiogenic factor thymidine phosphorylase and angiogenesis in human atherosclerosis.

J J Boyle1, B Wilson, R Bicknell, S Harrower, P L Weissberg, T P Fan.   

Abstract

In atherosclerosis, leukocyte migration into the plaque is thought to occur across the endothelium of the arterial lumen. However, intraplaque microvessels have been noted. While the significance of, and stimuli for these are uncertain, it seems possible that they may represent a second portal of entry for leukocytes into the plaque. This study performed a basic characterization of intraplaque microvessels and tested the hypothesis that the novel angiogenic factor thymidine phosphorylase (TP) is expressed in atherosclerosis. Immunocytochemistry was performed on aortic and coronary plaques and morphometry on coronary plaques. In plaques from both sites, macrophages, foam cells, and giant cells were immunoreactive for the angiogenic factors TP and vascular endothelial growth factor. Venule-like intraplaque microvessels expressed endothelial leukocyte adhesion molecules HLA-DR and ICAM-1, in contrast to the endothelium overlying the plaque. In coronary plaques, there was a correlation between severity of stenosis and plaque microvascular density. These results are consistent with a role for plaque macrophage/foam cell TP in stimulating plaque angiogenesis. While attention has focused on dysfunction of the endothelium overlying the plaque, microvascular endothelium may also represent a portal of entry for leukocytes into established plaques. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11004701     DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH699>3.0.CO;2-9

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  18 in total

1.  Thymidine phosphorylase inhibits vascular smooth muscle cell proliferation via upregulation of STAT3.

Authors:  Hong Yue; Kuniyoshi Tanaka; Tatsuhiko Furukawa; Sadashiva S Karnik; Wei Li
Journal:  Biochim Biophys Acta       Date:  2012-06-02

Review 2.  Multifunctional agents for concurrent imaging and therapy in cardiovascular disease.

Authors:  Jason R McCarthy
Journal:  Adv Drug Deliv Rev       Date:  2010-07-21       Impact factor: 15.470

Review 3.  Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions.

Authors:  G M Lanza; P M Winter; S D Caruthers; M S Hughes; Grace Hu; A H Schmieder; S A Wickline
Journal:  Angiogenesis       Date:  2010-04-22       Impact factor: 9.596

4.  Autocrine amplification of integrin αIIbβ3 activation and platelet adhesive responses by deoxyribose-1-phosphate.

Authors:  Dina S Vara; Michelangelo Campanella; Ilaria Canobbio; Warwick B Dunn; Giuseppe Pizzorno; Michio Hirano; Giordano Pula
Journal:  Thromb Haemost       Date:  2013-03-14       Impact factor: 5.249

5.  Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis.

Authors:  Patrick M Winter; Shelton D Caruthers; Huiying Zhang; Todd A Williams; Samuel A Wickline; Gregory M Lanza
Journal:  JACC Cardiovasc Imaging       Date:  2008-09

6.  Thymidine phosphorylase induces angiogenesis in vivo and in vitro: an evaluation of possible mechanisms.

Authors:  Shiladitya Sengupta; Lynda A Sellers; Hugh B Matheson; Tai-Ping D Fan
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

7.  Acute chest pain in a patient treated with capecitabine.

Authors:  C Camaro; P W Danse; H A Bosker
Journal:  Neth Heart J       Date:  2009-08       Impact factor: 2.380

8.  A case of capecitabine-induced coronary microspasm in a patient with rectal cancer.

Authors:  Leire Arbea; Isabel Coma-Canella; Rafael Martinez-Monge; Jesús García-Foncillas
Journal:  World J Gastroenterol       Date:  2007-04-14       Impact factor: 5.742

9.  Thymidine phosphorylase participates in platelet signaling and promotes thrombosis.

Authors:  Wei Li; Alba Gigante; Maria-Jesus Perez-Perez; Hong Yue; Michio Hirano; Thomas M McIntyre; Roy L Silverstein
Journal:  Circ Res       Date:  2014-10-06       Impact factor: 17.367

Review 10.  Thymidine phosphorylase: A potential new target for treating cardiovascular disease.

Authors:  Wei Li; Hong Yue
Journal:  Trends Cardiovasc Med       Date:  2017-10-20       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.